From multiply active natural product to candidate drug? Antibacterial (and other) minor groove binders for DNA

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Natural products that bind to DNA in the minor groove are valuable templates for drug design. Examples include distamycin, netropsin, duocarmycin and anthramycin. Anticancer and anti-infective drugs feature strongly amongst their derivatives. The structures and activities of chemotypes with various therapeutic actions are discussed in the context of the broader field of therapeutically active minor groove binders. The evolution of a series of exceptionally potent and nontoxic antibacterial compounds is discussed using the general design principle of introducing additional hydrophobicity into the distamycin template to increase the strength of binding to DNA. As well as potent antibacterial compounds, antifungal and antiparasitic compounds with exceptional cellular activity against trypanosomes have been identified. Possible mechanisms of action including gene regulation and topoisomerase inhibition are discussed with the need in mind to understand selective toxicity in the series to support future drug discovery.
LanguageEnglish
Pages971-989
Number of pages19
JournalFuture Medicinal Chemistry
Volume4
Issue number8
DOIs
Publication statusPublished - May 2012

Fingerprint

Biological Products
Anthramycin
Netropsin
Antiparasitic Agents
Trypanosomiasis
Drug Design
DNA
Gene Expression Regulation
Drug Discovery
Hydrophobic and Hydrophilic Interactions
Pharmaceutical Preparations
stallimycin
Therapeutics

Keywords

  • gram positive bacteria
  • resistant staphylococcus aureus
  • substituted thiazole polyamide
  • pyrrole imidazole polyamides
  • inverted CCAAT BOX-2
  • sequence recognition
  • antitumor activity
  • plasmodium-falciparum
  • molecular recognition

Cite this

@article{69df65f55acd4e3ca6d5b4373b1c1afa,
title = "From multiply active natural product to candidate drug? Antibacterial (and other) minor groove binders for DNA",
abstract = "Natural products that bind to DNA in the minor groove are valuable templates for drug design. Examples include distamycin, netropsin, duocarmycin and anthramycin. Anticancer and anti-infective drugs feature strongly amongst their derivatives. The structures and activities of chemotypes with various therapeutic actions are discussed in the context of the broader field of therapeutically active minor groove binders. The evolution of a series of exceptionally potent and nontoxic antibacterial compounds is discussed using the general design principle of introducing additional hydrophobicity into the distamycin template to increase the strength of binding to DNA. As well as potent antibacterial compounds, antifungal and antiparasitic compounds with exceptional cellular activity against trypanosomes have been identified. Possible mechanisms of action including gene regulation and topoisomerase inhibition are discussed with the need in mind to understand selective toxicity in the series to support future drug discovery.",
keywords = "gram positive bacteria, resistant staphylococcus aureus, substituted thiazole polyamide, pyrrole imidazole polyamides, inverted CCAAT BOX-2, sequence recognition, antitumor activity, plasmodium-falciparum, molecular recognition",
author = "Colin Suckling",
year = "2012",
month = "5",
doi = "10.4155/FMC.12.52",
language = "English",
volume = "4",
pages = "971--989",
journal = "Future Medicinal Chemistry",
issn = "1756-8919",
number = "8",

}

TY - JOUR

T1 - From multiply active natural product to candidate drug? Antibacterial (and other) minor groove binders for DNA

AU - Suckling, Colin

PY - 2012/5

Y1 - 2012/5

N2 - Natural products that bind to DNA in the minor groove are valuable templates for drug design. Examples include distamycin, netropsin, duocarmycin and anthramycin. Anticancer and anti-infective drugs feature strongly amongst their derivatives. The structures and activities of chemotypes with various therapeutic actions are discussed in the context of the broader field of therapeutically active minor groove binders. The evolution of a series of exceptionally potent and nontoxic antibacterial compounds is discussed using the general design principle of introducing additional hydrophobicity into the distamycin template to increase the strength of binding to DNA. As well as potent antibacterial compounds, antifungal and antiparasitic compounds with exceptional cellular activity against trypanosomes have been identified. Possible mechanisms of action including gene regulation and topoisomerase inhibition are discussed with the need in mind to understand selective toxicity in the series to support future drug discovery.

AB - Natural products that bind to DNA in the minor groove are valuable templates for drug design. Examples include distamycin, netropsin, duocarmycin and anthramycin. Anticancer and anti-infective drugs feature strongly amongst their derivatives. The structures and activities of chemotypes with various therapeutic actions are discussed in the context of the broader field of therapeutically active minor groove binders. The evolution of a series of exceptionally potent and nontoxic antibacterial compounds is discussed using the general design principle of introducing additional hydrophobicity into the distamycin template to increase the strength of binding to DNA. As well as potent antibacterial compounds, antifungal and antiparasitic compounds with exceptional cellular activity against trypanosomes have been identified. Possible mechanisms of action including gene regulation and topoisomerase inhibition are discussed with the need in mind to understand selective toxicity in the series to support future drug discovery.

KW - gram positive bacteria

KW - resistant staphylococcus aureus

KW - substituted thiazole polyamide

KW - pyrrole imidazole polyamides

KW - inverted CCAAT BOX-2

KW - sequence recognition

KW - antitumor activity

KW - plasmodium-falciparum

KW - molecular recognition

UR - http://www.scopus.com/inward/record.url?scp=84861849352&partnerID=8YFLogxK

U2 - 10.4155/FMC.12.52

DO - 10.4155/FMC.12.52

M3 - Article

VL - 4

SP - 971

EP - 989

JO - Future Medicinal Chemistry

T2 - Future Medicinal Chemistry

JF - Future Medicinal Chemistry

SN - 1756-8919

IS - 8

ER -